A Negative Feedback Loop Between NAMPT and TGF-β Signaling Pathway in Colorectal Cancer Cells

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.21551
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Wrobel P, Ahmed S. Current status of immunotherapy in metastatic colorectal cancer. Int J Colorectal Dis. 2019;34(1):13–25. doi:10.1007/s00384-018-3202-8
   PubMed Web of Science ®Google Scholar
• Wang N, Lu Y, Khankari NK, et al. Evaluation of genetic variants in association with colorectal cancer risk and survival in Asians. Int J Cancer. 2017;141(6):1130–1139. doi:10.1002/ijc.30812
   PubMed Web of Science ®Google Scholar
• Garten A, Schuster S, Penke M, Gorski T, de Giorgis T, Kiess W. Physiological and pathophysiological roles of NAMPT and NAD metabolism. Nat Rev Endocrinol. 2015;11(9):535–546.
   PubMed Web of Science ®Google Scholar
• Li XQ, Lei J, Mao LH, et al. NAMPT and NAPRT, key enzymes in NAD salvage synthesis pathway, are of negative prognostic value in colorectal cancer. Front Oncol. 2019;9:736. doi:10.3389/fonc.2019.00736
   PubMed Web of Science ®Google Scholar
• Chen M, Wang Y, Li Y, et al. Association of plasma visfatin with risk of colorectal cancer: an observational study of Chinese patients. Asia Pac J Clin Oncol. 2016;12(1):e65–74. doi:10.1111/ajco.12090
   PubMed Web of Science ®Google Scholar
• Lv X, Zhang L, Zhu Y, Said HM, Shi J, Xu G. Regulative effect of nampt on tumor progression and cell viability in human colorectal cancer. J Cancer. 2015;6(9):849–858. doi:10.7150/jca.12341
   PubMed Web of Science ®Google Scholar
• Heske CM. Beyond energy metabolism: exploiting the additional roles of NAMPT for cancer therapy. Front Oncol. 2020;9:1514. doi:10.3389/fonc.2019.01514
   PubMed Web of Science ®Google Scholar
• Yamaguchi D, Imaizumi T, Yagi K, et al. Nicotinamide phosphoribosyltransferase is a molecular target of potent anticancer agents identified from phenotype-based drug screening. Sci Rep. 2019;9(1):7742. doi:10.1038/s41598-019-43994-x
   PubMedGoogle Scholar
• Syed V. TGF-β signaling in cancer. J Cell Biochem. 2016;117(6):1279–1287. doi:10.1002/jcb.25496
   PubMed Web of Science ®Google Scholar
• Zhao M, Mishra L, Deng CX. The role of TGF-β/SMAD4 signaling in cancer. Int J Biol Sci. 2018;14(2):111–123. doi:10.7150/ijbs.23230
   PubMed Web of Science ®Google Scholar
• Rahimi RA, Leof EB. TGF-beta signaling: a tale of two responses. J Cell Biochem. 2007;102(3):593–608. doi:10.1002/jcb.21501
   PubMed Web of Science ®Google Scholar
• Seoane J, Gomis RR. TGF-β family signaling in tumor suppression and cancer progression. Cold Spring Harb Perspect Biol. 2017;9(12):a022277.
   PubMed Web of Science ®Google Scholar
• Attisano L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science. 2002;296(5573):1646–1647. doi:10.1126/science.1071809
   PubMed Web of Science ®Google Scholar
• Shi Y, Massagué J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113(6):685–700. doi:10.1016/S0092-8674(03)00432-X
   PubMed Web of Science ®Google Scholar
• Ma H, Wei Y, Leng Y, et al. TGF-β1-induced expression of Id-1 is associated with tumor progression in gastric cancer. Med Oncol. 2014;31(7):19. doi:10.1007/s12032-014-0019-3
   PubMed Web of Science ®Google Scholar
• Masuda T, Hayashi N, Kuroda Y, Ito S, Eguchi H, Mimori K. MicroRNAs as biomarkers in colorectal cancer. Cancers (Basel). 2017;9(9):124. doi:10.3390/cancers9090124
   PubMed Web of Science ®Google Scholar
• Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15(8):509–524.
   PubMed Web of Science ®Google Scholar
• Qu YL, Wang HF, Sun ZQ, et al. Up-regulated miR-155-5p promotes cell proliferation, invasion and metastasis in colorectal carcinoma. Int J Clin Exp Pathol. 2015;8(6):6988–6994.
   PubMed Web of Science ®Google Scholar
• Wang JY, Huang JC, Chen G, Wei DM. Expression level and potential target pathways of miR-1-3p in colorectal carcinoma based on 645 cases from 9 microarray datasets. Mol Med Rep. 2018;17(4):5013–5020.
   PubMed Web of Science ®Google Scholar
• Moreno EC, Pascual A, Prieto-Cuadra D, et al. Novel molecular characterization of colorectal primary tumors based on miRNAs. Cancers (Basel). 2019;11(3):346. doi:10.3390/cancers11030346
   PubMed Web of Science ®Google Scholar
• Mizuno H, Kitada K, Nakai K, Sarai A. PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genomics. 2009;2(1):18. doi:10.1186/1755-8794-2-18
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Databaseissue):D92–97. doi:10.1093/nar/gkt1248
   PubMed Web of Science ®Google Scholar
• Gholinejad Z, Kheiripour N, Nourbakhsh M, et al. Extracellular NAMPT/Visfatin induces proliferation through ERK1/2 and AKT and inhibits apoptosis in breast cancer cells. Peptides. 2017;92:9–15. doi:10.1016/j.peptides.2017.04.007
   PubMed Web of Science ®Google Scholar
• Guo Q, Han N, Shi L, et al. NAMPT: a potential prognostic and therapeutic biomarker in patients with glioblastoma. Oncol Rep. 2019;42(3):963–972.
   PubMed Web of Science ®Google Scholar
• Ju HQ, Zhuang ZN, Li H, et al. Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer. Cancer Lett. 2016;379(1):1–11. doi:10.1016/j.canlet.2016.05.024
   PubMed Web of Science ®Google Scholar
• Lucena-Cacace A, Otero-Albiol D, Jiménez-García MP, Muñoz-Galvan S, Carnero A. NAMPT is a potent oncogene in colon cancer progression that modulates cancer stem cell properties and resistance to therapy through Sirt1 and PARP. Clin Cancer Res. 2018;24(5):1202–1215. doi:10.1158/1078-0432.CCR-17-2575
   PubMed Web of Science ®Google Scholar
• Pan JH, Zhou H, Zhu SB, et al. Nicotinamide phosphoribosyl transferase regulates cell growth via the Sirt1/P53 signaling pathway and is a prognosis marker in colorectal cancer. J Cell Physiol. 2019;234(4):4385–4395. doi:10.1002/jcp.27228
   PubMed Web of Science ®Google Scholar
• Ye C, Qi L, Li X, et al. Targeting the NAD+ salvage pathway suppresses APC mutation-driven colorectal cancer growth and Wnt/β-catenin signaling via increasing axin level. Cell Commun Signal. 2020;18(1):16. doi:10.1186/s12964-020-0513-5
   PubMed Web of Science ®Google Scholar
• Gulubova M, Manolova I, Ananiev J, Julianov A, Yovchev Y, Peeva K. Role of TGF-beta1, its receptor TGFbetaRII, and Smad proteins in the progression of colorectal cancer. Int J Colorectal Dis. 2010;25(5):591–599. doi:10.1007/s00384-010-0906-9
   PubMed Web of Science ®Google Scholar
• Gachpazan M, Kashani H, Hassanian SM, et al. Therapeutic potential of targeting transforming growth factor-beta in colorectal cancer: rational and progress. Curr Pharm Des. 2019;25(38):4085–4089.
   PubMed Web of Science ®Google Scholar
• Brandl L, Kirstein N, Neumann J, et al. The c-MYC/NAMPT/SIRT1 feedback loop is activated in early classical and serrated route colorectal cancer and represents a therapeutic target. Med Oncol. 2018;36(1):5. doi:10.1007/s12032-018-1225-1
   PubMed Web of Science ®Google Scholar
• Soncini D, Caffa I, Zoppoli G, et al. Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity. J Biol Chem. 2014;289(49):34189–34204. doi:10.1074/jbc.M114.594721
   PubMed Web of Science ®Google Scholar
• Brown KA, Pietenpol JA, Moses HL. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. J Cell Biochem. 2007;101(1):9–33. doi:10.1002/jcb.21255
   PubMed Web of Science ®Google Scholar
• Liu L, Liu X, Ren X, et al. Smad2 and Smad3 have differential sensitivity in relaying TGFβ signaling and inversely regulate early lineage specification. Sci Rep. 2016;6(1):21602. doi:10.1038/srep21602
   PubMedGoogle Scholar
• Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330–337. doi:10.1038/nature11252
   PubMed Web of Science ®Google Scholar
• Itatani Y, Kawada K, Sakai Y. Transforming growth factor-β signaling pathway in colorectal cancer and its tumor microenvironment. Int J Mol Sci. 2019;20(23):5822. doi:10.3390/ijms20235822
   PubMed Web of Science ®Google Scholar
• Zhang C, Tong J, Huang G, El-Rifai W. Nicotinamide phosphoribosyl transferase (Nampt) is a target of microRNA-26b in colorectal cancer cells. PLoS One. 2013;8(7):e69963. doi:10.1371/journal.pone.0069963
   PubMed Web of Science ®Google Scholar